Approval · Notice of Compliance 15103 · 2014
ALLERTIN TABLETS: Notice of Compliance 15103
Issued January 6, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15103
- Date
- January 6, 2014
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Labelling Only
- Reason
- Brand name change
- Therapeutic class
- Histamine H1 receptor antagonist
- Canadian reference product
- CLARITIN (Schering Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALLERTIN TABLETS | 02418959 | Dormant |
Medicinal ingredients
- LORATADINE 10 MG per TAB